{"id":100796,"date":"2026-02-27T14:40:17","date_gmt":"2026-02-27T12:40:17","guid":{"rendered":"https:\/\/www.ipsen.com\/?p=100796"},"modified":"2026-02-27T15:29:18","modified_gmt":"2026-02-27T13:29:18","slug":"des-progres-pour-les-familles-confrontees-a-de-rares-tumeurs-cerebrales-pediatriques","status":"publish","type":"post","link":"https:\/\/www.ipsen.com\/fr\/actualites\/oncology-fr\/des-progres-pour-les-familles-confrontees-a-de-rares-tumeurs-cerebrales-pediatriques\/","title":{"rendered":"Des progr\u00e8s pour les familles confront\u00e9es \u00e0 de rares tumeurs c\u00e9r\u00e9brales p\u00e9diatriques"},"content":{"rendered":"\n<p><em>\u00c9crit par: <strong>Christelle Huguet<\/strong>, Directrice de la Recherche et du D\u00e9veloppement, Vice-Pr\u00e9sidente Ex\u00e9cutive<\/em><\/p>\n\n\n\n<p>Aujourd\u2019hui marque un moment important pour les enfants et les familles touch\u00e9s par l\u2019une des tumeurs c\u00e9r\u00e9brales p\u00e9diatriques rares les plus&nbsp;difficiles:&nbsp;le gliome p\u00e9diatrique de bas grade (pLGG).&nbsp;<\/p>\n\n\n\n<p>Chaque ann\u00e9e, des centaines d\u2019enfants en Europe re\u00e7oivent un diagnostic de&nbsp;pLGG. Pour beaucoup, le parcours implique des chirurgies invasives, des ann\u00e9es de chimioth\u00e9rapie intensive et l\u2019impact durable de complications potentielles affectant la vision, la parole et les fonctions neurologiques. En l\u2019absence de standard de soin mondial, les familles se retrouvent souvent confront\u00e9es \u00e0 l\u2019incertitude, \u00e0 la complexit\u00e9 et \u00e0 des choix extr\u00eamement difficiles, souvent pendant de nombreuses ann\u00e9es.&nbsp;<\/p>\n\n\n\n<p>C\u2019est pourquoi l\u2019annonce d\u2019aujourd\u2019hui est si significative. Ipsen a re\u00e7u un avis positif du CHMP pour un m\u00e9dicament qui, s\u2019il est approuv\u00e9, pourrait devenir le premier et le seul traitement cibl\u00e9 en Europe pour les enfants atteints d\u2019un&nbsp;pLGG&nbsp;alt\u00e9r\u00e9 par BRAF en rechute ou r\u00e9fractaire. Il pourrait transformer la mani\u00e8re dont nous soutenons les enfants vivant avec cette maladie implacable et \u00e9largir les options th\u00e9rapeutiques disponibles pour les m\u00e9decins qui prennent en charge cette pathologie complexe.&nbsp;<\/p>\n\n\n\n<p>Ce progr\u00e8s refl\u00e8te le d\u00e9vouement de nombreux scientifiques faisant avancer l\u2019innovation en oncologie rare, des m\u00e9decins, des participants aux essais cliniques et des partenaires apportant leur expertise en clinique, des enfants vivant avec un&nbsp;pLGG, de leurs proches et des associations de patients portant la voix des familles, ainsi que de nos \u00e9quipes chez Ipsen dont la passion et la pers\u00e9v\u00e9rance rendent possibles des avanc\u00e9es comme celle\u2011ci.&nbsp;<\/p>\n\n\n\n<p>Je suis&nbsp;honor\u00e9eet&nbsp;reconnaissante pour l&#8217;engagement qui a permis d\u2019atteindre cette \u00e9tape majeure.&nbsp;<\/p>\n\n\n\n<p>La Commission europ\u00e9enne va d\u00e9sormais examiner la recommandation du CHMP, avec une d\u00e9cision finale attendue dans les prochains mois.&nbsp;<\/p>\n\n\n\n<p>Des moments comme celui\u2011ci nous rappellent pourquoi ce travail est si important. Parce que les enfants et leurs familles m\u00e9ritent de meilleures options. Et parce que l\u2019innovation en oncologie p\u00e9diatrique ne peut pas attendre.&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u00c9crit par: Christelle Huguet, Directrice de la Recherche et du D\u00e9veloppement, Vice-Pr\u00e9sidente Ex\u00e9cutive Aujourd\u2019hui marque un moment important pour les<\/p>\n","protected":false},"author":9,"featured_media":49221,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[6024],"tags":[],"class_list":["post-100796","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-oncology-fr","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Des progr\u00e8s pour les familles confront\u00e9es \u00e0 de rares tumeurs c\u00e9r\u00e9brales p\u00e9diatriques<\/title>\n<meta name=\"description\" content=\"Chaque ann\u00e9e, des centaines d\u2019enfants en Europe re\u00e7oivent un diagnostic de pLGG. Pour beaucoup, le parcours implique des chirurgies invasives, des ann\u00e9es de chimioth\u00e9rapie intensive et l\u2019impact durable de complications potentielles affectant la vision, la parole et les fonctions neurologiques.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ipsen.com\/fr\/actualites\/oncology-fr\/des-progres-pour-les-familles-confrontees-a-de-rares-tumeurs-cerebrales-pediatriques\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Des progr\u00e8s pour les familles confront\u00e9es \u00e0 de rares tumeurs c\u00e9r\u00e9brales p\u00e9diatriques\" \/>\n<meta property=\"og:description\" content=\"Chaque ann\u00e9e, des centaines d\u2019enfants en Europe re\u00e7oivent un diagnostic de pLGG. Pour beaucoup, le parcours implique des chirurgies invasives, des ann\u00e9es de chimioth\u00e9rapie intensive et l\u2019impact durable de complications potentielles affectant la vision, la parole et les fonctions neurologiques.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ipsen.com\/fr\/actualites\/oncology-fr\/des-progres-pour-les-familles-confrontees-a-de-rares-tumeurs-cerebrales-pediatriques\/\" \/>\n<meta property=\"og:site_name\" content=\"Global\" \/>\n<meta property=\"article:published_time\" content=\"2026-02-27T12:40:17+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-27T13:29:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.ipsen.com\/wp-content\/uploads\/2024\/02\/Christelle-HUGUET_ELT-member_IPSEN-COM_756x506pix.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"756\" \/>\n\t<meta property=\"og:image:height\" content=\"506\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"konstantinoskampanos\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@ipsengroup\" \/>\n<meta name=\"twitter:site\" content=\"@ipsengroup\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"konstantinoskampanos\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.ipsen.com\/fr\/actualites\/oncology-fr\/des-progres-pour-les-familles-confrontees-a-de-rares-tumeurs-cerebrales-pediatriques\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.ipsen.com\/fr\/actualites\/oncology-fr\/des-progres-pour-les-familles-confrontees-a-de-rares-tumeurs-cerebrales-pediatriques\/\"},\"author\":{\"name\":\"konstantinoskampanos\",\"@id\":\"https:\/\/www.ipsen.com\/fr\/#\/schema\/person\/caf513ba91f9535b6b2d8a79d95764c5\"},\"headline\":\"Des progr\u00e8s pour les familles confront\u00e9es \u00e0 de rares tumeurs c\u00e9r\u00e9brales p\u00e9diatriques\",\"datePublished\":\"2026-02-27T12:40:17+00:00\",\"dateModified\":\"2026-02-27T13:29:18+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.ipsen.com\/fr\/actualites\/oncology-fr\/des-progres-pour-les-familles-confrontees-a-de-rares-tumeurs-cerebrales-pediatriques\/\"},\"wordCount\":402,\"publisher\":{\"@id\":\"https:\/\/www.ipsen.com\/fr\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.ipsen.com\/fr\/actualites\/oncology-fr\/des-progres-pour-les-familles-confrontees-a-de-rares-tumeurs-cerebrales-pediatriques\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.ipsen.com\/wp-content\/uploads\/2024\/02\/Christelle-HUGUET_ELT-member_IPSEN-COM_756x506pix.jpg\",\"articleSection\":[\"Oncologie\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.ipsen.com\/fr\/actualites\/oncology-fr\/des-progres-pour-les-familles-confrontees-a-de-rares-tumeurs-cerebrales-pediatriques\/\",\"url\":\"https:\/\/www.ipsen.com\/fr\/actualites\/oncology-fr\/des-progres-pour-les-familles-confrontees-a-de-rares-tumeurs-cerebrales-pediatriques\/\",\"name\":\"Des progr\u00e8s pour les familles confront\u00e9es \u00e0 de rares tumeurs c\u00e9r\u00e9brales p\u00e9diatriques\",\"isPartOf\":{\"@id\":\"https:\/\/www.ipsen.com\/fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.ipsen.com\/fr\/actualites\/oncology-fr\/des-progres-pour-les-familles-confrontees-a-de-rares-tumeurs-cerebrales-pediatriques\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.ipsen.com\/fr\/actualites\/oncology-fr\/des-progres-pour-les-familles-confrontees-a-de-rares-tumeurs-cerebrales-pediatriques\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.ipsen.com\/wp-content\/uploads\/2024\/02\/Christelle-HUGUET_ELT-member_IPSEN-COM_756x506pix.jpg\",\"datePublished\":\"2026-02-27T12:40:17+00:00\",\"dateModified\":\"2026-02-27T13:29:18+00:00\",\"description\":\"Chaque ann\u00e9e, des centaines d\u2019enfants en Europe re\u00e7oivent un diagnostic de pLGG. Pour beaucoup, le parcours implique des chirurgies invasives, des ann\u00e9es de chimioth\u00e9rapie intensive et l\u2019impact durable de complications potentielles affectant la vision, la parole et les fonctions neurologiques.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.ipsen.com\/fr\/actualites\/oncology-fr\/des-progres-pour-les-familles-confrontees-a-de-rares-tumeurs-cerebrales-pediatriques\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.ipsen.com\/fr\/actualites\/oncology-fr\/des-progres-pour-les-familles-confrontees-a-de-rares-tumeurs-cerebrales-pediatriques\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.ipsen.com\/fr\/actualites\/oncology-fr\/des-progres-pour-les-familles-confrontees-a-de-rares-tumeurs-cerebrales-pediatriques\/#primaryimage\",\"url\":\"https:\/\/www.ipsen.com\/wp-content\/uploads\/2024\/02\/Christelle-HUGUET_ELT-member_IPSEN-COM_756x506pix.jpg\",\"contentUrl\":\"https:\/\/www.ipsen.com\/wp-content\/uploads\/2024\/02\/Christelle-HUGUET_ELT-member_IPSEN-COM_756x506pix.jpg\",\"width\":756,\"height\":506},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.ipsen.com\/fr\/actualites\/oncology-fr\/des-progres-pour-les-familles-confrontees-a-de-rares-tumeurs-cerebrales-pediatriques\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.ipsen.com\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Des progr\u00e8s pour les familles confront\u00e9es \u00e0 de rares tumeurs c\u00e9r\u00e9brales p\u00e9diatriques\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.ipsen.com\/fr\/#website\",\"url\":\"https:\/\/www.ipsen.com\/fr\/\",\"name\":\"Global\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.ipsen.com\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.ipsen.com\/fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.ipsen.com\/fr\/#organization\",\"name\":\"IPSEN\",\"url\":\"https:\/\/www.ipsen.com\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.ipsen.com\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.ipsen.com\/wp-content\/uploads\/2023\/12\/Latest_Ipsen-logo_168x48.svg\",\"contentUrl\":\"https:\/\/www.ipsen.com\/wp-content\/uploads\/2023\/12\/Latest_Ipsen-logo_168x48.svg\",\"caption\":\"IPSEN\"},\"image\":{\"@id\":\"https:\/\/www.ipsen.com\/fr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/Ipsengroup\",\"https:\/\/x.com\/ipsengroup\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.ipsen.com\/fr\/#\/schema\/person\/caf513ba91f9535b6b2d8a79d95764c5\",\"name\":\"konstantinoskampanos\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.ipsen.com\/fr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/461d8aaa3dc000968b96f9df6ebfd0f045990cabf9f91de7f7dc4b9542e2adc8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/461d8aaa3dc000968b96f9df6ebfd0f045990cabf9f91de7f7dc4b9542e2adc8?s=96&d=mm&r=g\",\"caption\":\"konstantinoskampanos\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Des progr\u00e8s pour les familles confront\u00e9es \u00e0 de rares tumeurs c\u00e9r\u00e9brales p\u00e9diatriques","description":"Chaque ann\u00e9e, des centaines d\u2019enfants en Europe re\u00e7oivent un diagnostic de pLGG. Pour beaucoup, le parcours implique des chirurgies invasives, des ann\u00e9es de chimioth\u00e9rapie intensive et l\u2019impact durable de complications potentielles affectant la vision, la parole et les fonctions neurologiques.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ipsen.com\/fr\/actualites\/oncology-fr\/des-progres-pour-les-familles-confrontees-a-de-rares-tumeurs-cerebrales-pediatriques\/","og_locale":"fr_FR","og_type":"article","og_title":"Des progr\u00e8s pour les familles confront\u00e9es \u00e0 de rares tumeurs c\u00e9r\u00e9brales p\u00e9diatriques","og_description":"Chaque ann\u00e9e, des centaines d\u2019enfants en Europe re\u00e7oivent un diagnostic de pLGG. Pour beaucoup, le parcours implique des chirurgies invasives, des ann\u00e9es de chimioth\u00e9rapie intensive et l\u2019impact durable de complications potentielles affectant la vision, la parole et les fonctions neurologiques.","og_url":"https:\/\/www.ipsen.com\/fr\/actualites\/oncology-fr\/des-progres-pour-les-familles-confrontees-a-de-rares-tumeurs-cerebrales-pediatriques\/","og_site_name":"Global","article_published_time":"2026-02-27T12:40:17+00:00","article_modified_time":"2026-02-27T13:29:18+00:00","og_image":[{"width":756,"height":506,"url":"https:\/\/www.ipsen.com\/wp-content\/uploads\/2024\/02\/Christelle-HUGUET_ELT-member_IPSEN-COM_756x506pix.jpg","type":"image\/jpeg"}],"author":"konstantinoskampanos","twitter_card":"summary_large_image","twitter_creator":"@ipsengroup","twitter_site":"@ipsengroup","twitter_misc":{"Written by":"konstantinoskampanos","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.ipsen.com\/fr\/actualites\/oncology-fr\/des-progres-pour-les-familles-confrontees-a-de-rares-tumeurs-cerebrales-pediatriques\/#article","isPartOf":{"@id":"https:\/\/www.ipsen.com\/fr\/actualites\/oncology-fr\/des-progres-pour-les-familles-confrontees-a-de-rares-tumeurs-cerebrales-pediatriques\/"},"author":{"name":"konstantinoskampanos","@id":"https:\/\/www.ipsen.com\/fr\/#\/schema\/person\/caf513ba91f9535b6b2d8a79d95764c5"},"headline":"Des progr\u00e8s pour les familles confront\u00e9es \u00e0 de rares tumeurs c\u00e9r\u00e9brales p\u00e9diatriques","datePublished":"2026-02-27T12:40:17+00:00","dateModified":"2026-02-27T13:29:18+00:00","mainEntityOfPage":{"@id":"https:\/\/www.ipsen.com\/fr\/actualites\/oncology-fr\/des-progres-pour-les-familles-confrontees-a-de-rares-tumeurs-cerebrales-pediatriques\/"},"wordCount":402,"publisher":{"@id":"https:\/\/www.ipsen.com\/fr\/#organization"},"image":{"@id":"https:\/\/www.ipsen.com\/fr\/actualites\/oncology-fr\/des-progres-pour-les-familles-confrontees-a-de-rares-tumeurs-cerebrales-pediatriques\/#primaryimage"},"thumbnailUrl":"https:\/\/www.ipsen.com\/wp-content\/uploads\/2024\/02\/Christelle-HUGUET_ELT-member_IPSEN-COM_756x506pix.jpg","articleSection":["Oncologie"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/www.ipsen.com\/fr\/actualites\/oncology-fr\/des-progres-pour-les-familles-confrontees-a-de-rares-tumeurs-cerebrales-pediatriques\/","url":"https:\/\/www.ipsen.com\/fr\/actualites\/oncology-fr\/des-progres-pour-les-familles-confrontees-a-de-rares-tumeurs-cerebrales-pediatriques\/","name":"Des progr\u00e8s pour les familles confront\u00e9es \u00e0 de rares tumeurs c\u00e9r\u00e9brales p\u00e9diatriques","isPartOf":{"@id":"https:\/\/www.ipsen.com\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.ipsen.com\/fr\/actualites\/oncology-fr\/des-progres-pour-les-familles-confrontees-a-de-rares-tumeurs-cerebrales-pediatriques\/#primaryimage"},"image":{"@id":"https:\/\/www.ipsen.com\/fr\/actualites\/oncology-fr\/des-progres-pour-les-familles-confrontees-a-de-rares-tumeurs-cerebrales-pediatriques\/#primaryimage"},"thumbnailUrl":"https:\/\/www.ipsen.com\/wp-content\/uploads\/2024\/02\/Christelle-HUGUET_ELT-member_IPSEN-COM_756x506pix.jpg","datePublished":"2026-02-27T12:40:17+00:00","dateModified":"2026-02-27T13:29:18+00:00","description":"Chaque ann\u00e9e, des centaines d\u2019enfants en Europe re\u00e7oivent un diagnostic de pLGG. Pour beaucoup, le parcours implique des chirurgies invasives, des ann\u00e9es de chimioth\u00e9rapie intensive et l\u2019impact durable de complications potentielles affectant la vision, la parole et les fonctions neurologiques.","breadcrumb":{"@id":"https:\/\/www.ipsen.com\/fr\/actualites\/oncology-fr\/des-progres-pour-les-familles-confrontees-a-de-rares-tumeurs-cerebrales-pediatriques\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ipsen.com\/fr\/actualites\/oncology-fr\/des-progres-pour-les-familles-confrontees-a-de-rares-tumeurs-cerebrales-pediatriques\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.ipsen.com\/fr\/actualites\/oncology-fr\/des-progres-pour-les-familles-confrontees-a-de-rares-tumeurs-cerebrales-pediatriques\/#primaryimage","url":"https:\/\/www.ipsen.com\/wp-content\/uploads\/2024\/02\/Christelle-HUGUET_ELT-member_IPSEN-COM_756x506pix.jpg","contentUrl":"https:\/\/www.ipsen.com\/wp-content\/uploads\/2024\/02\/Christelle-HUGUET_ELT-member_IPSEN-COM_756x506pix.jpg","width":756,"height":506},{"@type":"BreadcrumbList","@id":"https:\/\/www.ipsen.com\/fr\/actualites\/oncology-fr\/des-progres-pour-les-familles-confrontees-a-de-rares-tumeurs-cerebrales-pediatriques\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.ipsen.com\/fr\/"},{"@type":"ListItem","position":2,"name":"Des progr\u00e8s pour les familles confront\u00e9es \u00e0 de rares tumeurs c\u00e9r\u00e9brales p\u00e9diatriques"}]},{"@type":"WebSite","@id":"https:\/\/www.ipsen.com\/fr\/#website","url":"https:\/\/www.ipsen.com\/fr\/","name":"Global","description":"","publisher":{"@id":"https:\/\/www.ipsen.com\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ipsen.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.ipsen.com\/fr\/#organization","name":"IPSEN","url":"https:\/\/www.ipsen.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.ipsen.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.ipsen.com\/wp-content\/uploads\/2023\/12\/Latest_Ipsen-logo_168x48.svg","contentUrl":"https:\/\/www.ipsen.com\/wp-content\/uploads\/2023\/12\/Latest_Ipsen-logo_168x48.svg","caption":"IPSEN"},"image":{"@id":"https:\/\/www.ipsen.com\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/Ipsengroup","https:\/\/x.com\/ipsengroup"]},{"@type":"Person","@id":"https:\/\/www.ipsen.com\/fr\/#\/schema\/person\/caf513ba91f9535b6b2d8a79d95764c5","name":"konstantinoskampanos","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.ipsen.com\/fr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/461d8aaa3dc000968b96f9df6ebfd0f045990cabf9f91de7f7dc4b9542e2adc8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/461d8aaa3dc000968b96f9df6ebfd0f045990cabf9f91de7f7dc4b9542e2adc8?s=96&d=mm&r=g","caption":"konstantinoskampanos"}}]}},"jetpack_featured_media_url":"https:\/\/www.ipsen.com\/wp-content\/uploads\/2024\/02\/Christelle-HUGUET_ELT-member_IPSEN-COM_756x506pix.jpg","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/posts\/100796","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/comments?post=100796"}],"version-history":[{"count":2,"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/posts\/100796\/revisions"}],"predecessor-version":[{"id":100798,"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/posts\/100796\/revisions\/100798"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/media\/49221"}],"wp:attachment":[{"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/media?parent=100796"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/categories?post=100796"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/tags?post=100796"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}